0001493152-24-040432.txt : 20241008
0001493152-24-040432.hdr.sgml : 20241008
20241008160511
ACCESSION NUMBER: 0001493152-24-040432
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20241008
DATE AS OF CHANGE: 20241008
EFFECTIVENESS DATE: 20241008
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncocyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-526205
FILM NUMBER: 241360366
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20200213
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
D
1
primary_doc.xml
X0708
D
LIVE
0001642380
Oncocyte Corp
15 CUSHING
IRVINE
CA
CALIFORNIA
92618
(949) 409-7600
CALIFORNIA
None
OncoCyte Corp
Oncocyte Corp
Corporation
true
Joshua
Riggs
15 Cushing
Irvine
CA
CALIFORNIA
92618
Executive Officer
Director
President and Chief Executive Officer and Director
James
Liu
15 Cushing
Irvine
CA
CALIFORNIA
92618
Executive Officer
Senior Director, Controller & Principal Accounting Officer
Louis
Silverman
15 Cushing
Irvine
CA
CALIFORNIA
92618
Director
Andrew
Arno
15 Cushing
Irvine
CA
CALIFORNIA
92618
Director
Andrew
Last
15 Cushing
Irvine
CA
CALIFORNIA
92618
Director
Andrea
James
15 Cushing
Irvine
CA
CALIFORNIA
92618
Executive Officer
Chief Financial Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-10-02
false
true
false
0
Needham & Company, LLC
000016360
None
None
250 Park Avenue
10th Floor
New York
NY
NEW YORK
10177
NY
NEW YORK
false
10204262
10204262
0
false
16
250000
true
0
0
false
Oncocyte Corp
/s/ Joshua Riggs
Joshua Riggs
President and Chief Executive Officer and Director
2024-10-08